发明名称 HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
摘要 Disclosed is a peptide having an ability to bind to an HLA-A*1101 molecule, and an ability to induce a cytotoxic T lymphocyte (CTL). Also disclosed are peptide dimers, the use of the peptides in the manufacture of a medicament, expression vectors, pharmaceutical compositions, WT1-specific cytotoxic T lymphocyte, wherein said cytotoxic T lymphocyte has been induced by the peptide and methods for induction of WT1-specific cytotoxic T lymphocytes.
申请公布号 NZ577443(A) 申请公布日期 2011.12.22
申请号 NZ20070577443 申请日期 2007.12.14
申请人 INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC. 发明人 SUGIYAMA, HARUO
分类号 C12Q1/02;A61K31/7088;A61K38/00;A61K48/00;A61P35/00;A61P35/02;C07K14/82;C12N15/12;G01N33/574 主分类号 C12Q1/02
代理机构 代理人
主权项
地址